马氏棒状杆菌是杰氏棒状杆菌复合群人类感染主要基因组种
研究对日本单中心6例及8家医院33株血流感染菌株行全基因组测序,并将全球66株复合群菌株基因组数据合并分析。结果显示,MALDI-TOF MS鉴定为杰氏棒状杆菌的菌株中97.0%(32/33)基因组实为马氏棒状杆菌,全球菌株中77.3%(51/66)为马氏棒状杆菌,该菌多耐药但对teicoplanin等抗MRSA药物敏感。
要点
- MALDI-TOF MS鉴定为杰氏棒状杆菌的菌株绝大多数基因组实为马氏棒状杆菌。
- 马氏棒状杆菌多耐药,但teicoplanin等抗MRSA药物均具良好活性。
- 无tet(W)基因菌株(22/38,57.9%)对四环素类敏感,可指导用药。
核心结论
- 马氏棒状杆菌是杰氏棒状杆菌复合群引起人类感染的主要基因组种。
- 该菌多耐药,但抗MRSA药物(含teicoplanin)活性良好。
研究设计与样本
- 单中心9年6例感染菌株及8家医院33株血流感染菌株行全基因组测序和药敏试验。
- 合并全球公开66株杰氏棒状杆菌复合群基因组数据确定基因组种分布。
主要发现
- 单中心6例感染菌株基因组均鉴定为马氏棒状杆菌。
- 8中心研究中MALDI-TOF MS鉴定为杰氏棒状杆菌的32/33(97.0%)基因组实为马氏棒状杆菌。
- 核心基因组SNP分析提示3对菌株存在院内传播。
- 全球66株复合群菌株中51株(77.3%)重新鉴定为马氏棒状杆菌。
关键数值与推荐
- 无tet(W)基因菌株22/38(57.9%)对四环素类敏感。
- 所有抗MRSA药物(包括teicoplanin)对马氏棒状杆菌具良好活性。
临床怎么用
- MALDI-TOF MS鉴定为杰氏棒状杆菌时,应意识到可能实为马氏棒状杆菌。
- 治疗可优先考虑teicoplanin等抗MRSA药物,无tet(W)基因者可选用四环素类。
- 对疑似院内传播病例可行核心基因组SNP分析辅助溯源。
局限性
- 单中心病例数较少(6例),临床信息有限。
- 全球基因组数据主要来自临床菌株,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genomic characteristics and optimal treatment of Corynebacterium jeikeium remain largely unknown. We collected clinical information and performed whole-genome sequencing analysis of the causative strains of six cases of C. jeikeium infection at a single hospital over a 9-year period. Additionally, whole-genome sequencing analysis was performed on 33 C. jeikeium strains from cases of bloodstream infection at eight hospitals. Antimicrobial susceptibility testing was performed, and the results were compared to the resistance genes identified. Publicly available genome data of strains of C. jeikeium complex, consisting of C. jeikeium sensu stricto, Corynebacterium macclintockiae, and Corynebacterium evansiae, worldwide, were combined with the data from this study to determine the distribution of genomic species. In the single-center study, cases of prosthetic osteoarticular infection, postoperative intra-abdominal infection, and catheter-related bloodstream infection were identified, and the causative strains were genomically identified as C. macclintockiae. All but one isolate (32/33, 97.0%) in the eight-center study identified as C. jeikeium by matrix-assisted laser desorption ionization-time of flight mass spectrometry were also genomically identified as C. macclintockiae. Nosocomial transmission was suggested in three strain pairs by core-genome single nucleotide polymorphism analysis. C. macclintockiae strains were generally multidrug-resistant, but all anti-methicillin-resistant Staphylococcus aureus agents, including teicoplanin, had favorable activity, and the strains without the tet(W) gene (22/38, 57.9%) were susceptible to tetracyclines. Genome analysis of 66 C. jeikeium complex strains collected worldwide, consisting mainly of clinical strains, re-identified 51 strains (77.3%) as C. macclintockiae. This study demonstrates that C. macclintockiae is the major genomic species of the C. jeikeium complex causing human infections.IMPORTANCERecent widespread use of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has facilitated the identification of Corynebacterium spp. in microbiology laboratories, thereby raising awareness of the clinical importance of these organisms. Nevertheless, the accumulation of information on genomic characteristics of Corynebacterium jeikeium has been significantly limited compared to other pathogenic organisms thus far. In this study, we analyzed causative strains of infections identified as C. jeikeium by MALDI-TOF MS, collected from multiple institutions throughout Japan, and found that most of these strains were genomically identified as Corynebacterium macclintockiae, a species that has been newly described recently. Collection of clinical information on selected cases showed that C. macclintockiae indeed caused invasive infections that required intravenous or long-term oral antimicrobial therapy. Additional analyses using genomic data of C. jeikeium complex strains registered in public databases suggest that C. macclintockiae is of global clinical importance.
引用
- Harada S, Komori K, Yukawa K, et al. Genomic epidemiology and antimicrobial resistance of Corynebacterium macclintockiae, the predominant species of human pathogens within the Corynebacterium jeikeium complex. J Clin Microbiol. 2025. PMID: 40704802. doi:10.1128/jcm.00500-25
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。